Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02939638 · ClinicalTrials.gov registry record · NA
Diet, Insulin Sensitivity, and Postprandial Metabolism
A NA study, sponsored by Physicians Committee for Responsible Medicine.
- Completed
- Registry status
- NA
- Development phase
- 220
- Enrollment target
NCT02939638: Completed NA study, sponsored by Physicians Committee for Responsible Medicine.
NCT02939638 is a NA study that has completed, run by Physicians Committee for Responsible Medicine. The registered enrollment target is 220 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02939638, a NA study, has completed, sponsored by Physicians Committee for Responsible Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
Study Summary
This randomized, controlled trial aims to elucidate the mechanisms by which a plant-based dietary intervention causes weight loss. Using a low-fat, plant-based diet for 16 weeks, along with an untreated control for comparison, the study will measure changes in body weight, body composition, intramyocellular and/or intrahepatocellular lipid, and changes in association to body weight.
Primary Outcome
Anticipated weight-loss for intervention group compared with control group. Weight and height will be combined to report BMI in kg/m\^2
Interventions
- OTHER Control Diet
- OTHER Plant-based diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2016-10 |
| Est. Completion | 2019-01-09 |
| Phase | NA |
What the finished NCT02939638 record still lists
NCT02939638 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).
The record links to 0 conditions, and to 2 interventions - of which Control Diet is the first listed.
NCT02939638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02939638 about?
NCT02939638 is a clinical study titled "Diet, Insulin Sensitivity, and Postprandial Metabolism". This randomized, controlled trial aims to elucidate the mechanisms by which a plant-based dietary intervention causes weight loss. Using a low-fat, plant-based diet for 16 weeks, along with an untreated control for comparison, the study will measure changes in body weight, body composition, intramyo...
What is the current status of trial NCT02939638?
This trial is currently completed. It is a NA study. The enrollment target is 220 participants. The study started on 2016-10. Estimated completion is 2019-01-09.
What interventions are being tested in trial NCT02939638?
The interventions under investigation include: Control Diet (OTHER), Plant-based diet (OTHER).
Who is sponsoring clinical trial NCT02939638?
This trial is sponsored by Physicians Committee for Responsible Medicine, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02939638's enrollment target sits among peer trials
220 481st of 2000 higher than 1,516 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia